About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
Anyone can get colorectal cancer. Doctors often don't know why it happens, but they know some of the things that make people more likely to get it. These include: Age. The disease is most common ...
A recent American Cancer Society report highlights the increasing incidence of colorectal cancer in young adults. Understanding risk factors and recognizing symptoms are crucial for early detection ...
Results that may be inaccessible to you are currently showing.